Literature DB >> 11096095

Hypercontractile properties of cardiac muscle fibers in a knock-in mouse model of cardiac myosin-binding protein-C.

C C Witt1, B Gerull, M J Davies, T Centner, W A Linke, L Thierfelder.   

Abstract

Myosin-binding protein-C (MyBP-C) is a component of all striated-muscle sarcomeres, with a well established structural role and a possible function for force regulation. Multiple mutations within the gene for cardiac MyBP-C, one of three known isoforms, have been linked to familial hypertrophic cardiomyopathy. Here we generated a knock-in mouse model that carries N-terminal-shortened cardiac MyBP-C. The mutant protein was designed to have a similar size as the skeletal MyBP-C isoforms, whereas known myosin and titin binding sites as well as the phosphorylatable MyBP-C motif were not altered. We have shown that mutant cardiac MyBP-C is readily incorporated into the sarcomeres of both heterozygous and homozygous animals and can still be phosphorylated by cAMP-dependent protein kinase. Although histological characterization of wild-type and mutant hearts did not reveal obvious differences in phenotype, left ventricular fibers from homozygous mutant mice exhibited an increased Ca(2+) sensitivity of force development, particularly at lower Ca(2+) concentrations, whereas maximal active force levels remained unchanged. The results allow us to propose a model of how cMyBP-C may affect myosin-head mobility and to rationalize why N-terminal mutations of the protein in some cases of familial hypertrophic cardiomyopathy could lead to a hypercontractile state.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11096095     DOI: 10.1074/jbc.M008691200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  28 in total

Review 1.  Structure, interactions and function of the N-terminus of cardiac myosin binding protein C (MyBP-C): who does what, with what, and to whom?

Authors:  Mark Pfuhl; Mathias Gautel
Journal:  J Muscle Res Cell Motil       Date:  2012-04-20       Impact factor: 2.698

Review 2.  Myofibrillar remodeling in cardiac hypertrophy, heart failure and cardiomyopathies.

Authors:  Jarmila Machackova; Judit Barta; Naranjan S Dhalla
Journal:  Can J Cardiol       Date:  2006-09       Impact factor: 5.223

Review 3.  Build it up-Tear it down: protein quality control in the cardiac sarcomere.

Authors:  Monte S Willis; Jonathan C Schisler; Andrea L Portbury; Cam Patterson
Journal:  Cardiovasc Res       Date:  2008-10-29       Impact factor: 10.787

4.  Cardiac myosin binding protein-C modulates actomyosin binding and kinetics in the in vitro motility assay.

Authors:  Walid Saber; Kelly J Begin; David M Warshaw; Peter VanBuren
Journal:  J Mol Cell Cardiol       Date:  2008-03-29       Impact factor: 5.000

5.  Differential contribution of cardiac sarcomeric proteins in the myofibrillar force response to stretch.

Authors:  Younss Ait Mou; Jean-Yves le Guennec; Emilio Mosca; Pieter P de Tombe; Olivier Cazorla
Journal:  Pflugers Arch       Date:  2008-05-01       Impact factor: 3.657

Review 6.  Molecular genetics and pathogenesis of cardiomyopathy.

Authors:  Akinori Kimura
Journal:  J Hum Genet       Date:  2015-07-16       Impact factor: 3.172

Review 7.  Mendelian forms of structural cardiovascular disease.

Authors:  Calum A MacRae
Journal:  Curr Cardiol Rep       Date:  2013-10       Impact factor: 2.931

8.  In vivo definition of cardiac myosin-binding protein C's critical interactions with myosin.

Authors:  Md Shenuarin Bhuiyan; Patrick McLendon; Jeanne James; Hanna Osinska; James Gulick; Bidur Bhandary; John N Lorenz; Jeffrey Robbins
Journal:  Pflugers Arch       Date:  2016-08-27       Impact factor: 3.657

Review 9.  Phosphorylation and function of cardiac myosin binding protein-C in health and disease.

Authors:  David Barefield; Sakthivel Sadayappan
Journal:  J Mol Cell Cardiol       Date:  2009-12-03       Impact factor: 5.000

10.  Phosphorylation modulates the mechanical stability of the cardiac myosin-binding protein C motif.

Authors:  Arthur J Michalek; Jack W Howarth; James Gulick; Michael J Previs; Jeffrey Robbins; Paul R Rosevear; David M Warshaw
Journal:  Biophys J       Date:  2013-01-22       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.